These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 23619510

  • 1. ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein.
    Dickens D, Owen A, Alfirevic A, Pirmohamed M.
    Pharmacogenet Genomics; 2013 Jun; 23(6):314-23. PubMed ID: 23619510
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate.
    Ali MA, Elsalakawy WA.
    Med Oncol; 2014 Nov; 31(11):279. PubMed ID: 25301112
    [Abstract] [Full Text] [Related]

  • 7. Effect of ABCB1 (MDR1) 3435C >T and 2677G >A,T polymorphisms and P-glycoprotein inhibitors on salivary digoxin secretion in congestive heart failure patients.
    Bartnicka L, Kurzawski M, Drozdzik A, Plonska-Gosciniak E, Górnik W, Drozdzik M.
    Pharmacol Rep; 2007 Nov; 59(3):323-9. PubMed ID: 17652833
    [Abstract] [Full Text] [Related]

  • 8. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients.
    Kurzawski M, Bartnicka L, Florczak M, Górnik W, Droździk M.
    Pharmacol Rep; 2007 Nov; 59(1):107-11. PubMed ID: 17377214
    [Abstract] [Full Text] [Related]

  • 9. Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib.
    Dessilly G, Panin N, Elens L, Haufroid V, Demoulin JB.
    Sci Rep; 2016 Jul 12; 6():29559. PubMed ID: 27405085
    [Abstract] [Full Text] [Related]

  • 10. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
    Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M.
    Int J Colorectal Dis; 2009 Aug 12; 24(8):895-905. PubMed ID: 19415305
    [Abstract] [Full Text] [Related]

  • 11. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A, Gutmann H, Drewe J.
    Mol Pharm; 2010 Oct 04; 7(5):1618-28. PubMed ID: 20701289
    [Abstract] [Full Text] [Related]

  • 12. P-glycoprotein mechanical functional analysis using in silico molecular modeling: Pharmacokinetic variability according to ABCB1 c.2677G > T/A genetic polymorphisms.
    Jeong SH, Jang JH, Lee YB.
    Int J Biol Macromol; 2023 Sep 30; 249():126777. PubMed ID: 37683742
    [Abstract] [Full Text] [Related]

  • 13. Substrate-dependent effects of human ABCB1 coding polymorphisms.
    Gow JM, Hodges LM, Chinn LW, Kroetz DL.
    J Pharmacol Exp Ther; 2008 May 30; 325(2):435-42. PubMed ID: 18287207
    [Abstract] [Full Text] [Related]

  • 14. Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users.
    Neuvonen AM, Palo JU, Sajantila A.
    Int J Legal Med; 2011 Mar 30; 125(2):265-9. PubMed ID: 21311904
    [Abstract] [Full Text] [Related]

  • 15. Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell lines.
    De Greef J, Akue M, Panin N, Delongie KA, André M, Mahieu G, Hoste E, Elens L, Belkhir L, Haufroid V.
    Sci Rep; 2024 Jul 15; 14(1):16290. PubMed ID: 39009738
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.
    Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, Molimard M, Krajinovic M, Mahon FX.
    Blood; 2008 Sep 01; 112(5):2024-7. PubMed ID: 18524988
    [Abstract] [Full Text] [Related]

  • 17. Degree of kinase inhibition achieved in vitro by imatinib and nilotinib is decreased by high levels of ABCB1 but not ABCG2.
    Eadie LN, Saunders VA, Hughes TP, White DL.
    Leuk Lymphoma; 2013 Mar 01; 54(3):569-78. PubMed ID: 22845311
    [Abstract] [Full Text] [Related]

  • 18. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S, Camenisch G, Lemaire M, Scherrmann JM.
    J Neurochem; 2007 Sep 01; 102(6):1749-1757. PubMed ID: 17696988
    [Abstract] [Full Text] [Related]

  • 19. Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.
    Moss DM, Liptrott NJ, Curley P, Siccardi M, Back DJ, Owen A.
    Antimicrob Agents Chemother; 2013 Nov 01; 57(11):5612-8. PubMed ID: 24002095
    [Abstract] [Full Text] [Related]

  • 20. Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population.
    Krivulcik T, Sedlak J, Bartosova Z.
    Neoplasma; 2009 Nov 01; 56(2):101-7. PubMed ID: 19239322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.